Core Viewpoint - The company, KeFu Medical, is focusing on a "product-centric" strategy, emphasizing the development of key products such as ventilators, hearing aids, posture correction belts, and blood glucose and uric acid monitoring devices [1] Group 1: Strategic Investments - The company has made strategic investments in the brain-computer interface sector, indicating a strong interest in this emerging field [1] - In May 2024, the company invested in NewLink Medical, acquiring a 5.83% stake, which specializes in implantable brain-computer interface technology, particularly in developing bionic eye and ear products [1] - This investment aligns with the company's existing hearing business, especially in addressing congenital hearing loss [1] Group 2: Future Collaborations - By the end of 2025, the company plans to invest in Lizi Intelligent, holding a 12.45% stake, focusing on non-invasive brain-computer interface robotics [1] - This future investment is expected to create strategic synergies with the company's rehabilitation aids and respiratory support products [1] - The strategic entry into the brain-computer interface field not only enhances the potential for collaboration within existing businesses but also lays the groundwork for future technological integration and industry upgrades [1]
可孚医疗：2024年5月公司投资纽聆氪医疗，持股比例5.83%